NEWTOWN, PA., January 16th, 2012 – Quotient Biodiagnostics, Inc. (“Quotient”), a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare institutions, is pleased to announce that its range of ALBAcyte® Reagent Red Blood Cell products have been licensed for sale in the USA by the Food and Drug Administration (FDA).
“Licensing of the ALBAcyte® Reagent Red Blood Cell products by the FDA satisfi…
Quotient now an approved vendor for Veteran's Affairs, Indian Health Services, and other government hospitals through General Services Agency Contract
NEWTOWN, PA (December 1, 2011) Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has been awarded a five year contract to supply its blood bank reagents to the federal government. Through the Federal Supply Schedule, Quotient…
ATTENDEES RATE PROGRAM 3.9 OUT OF 4.0
NEWTOWN, PA (October 24, 2011) Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today hosted an Industry Workshop entitled "The Myth and Mystery of RhD" at the 2011 Annual Meeting of the AABB. The program consisted of three presentations by an august set of panelists.
BGA is a Buying Cooperative Representing 69 Independent Blood Center Members
December 13, 2010
NEWTOWN, PA (December 13, 2010 Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today announced that it has entered into a supply agreement with Blood Group Alliance (BGA). BGA will promote Quotient’s product line to its blood center member organizations, which account for over 50% percent of the nation’…
November 01, 2010
NEWTOWN, PA. (November 1, 2010) - Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to hospitals and blood banks, today announced that it had launched two new products including: ALBAcyte® IgG Sensitized Cells and ALBAlect® Anti-A1 Lectin.
New ALBAcyte® IgG Sensitized Cells can cost 40-60% less than primary competitors.
August 31, 2010
NEWTOWN, Penn. (August 31, 2010)—Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to hospitals and blood banks, today announced that it has entered into a three-year agreement with the American Red Cross.
Quotient Biodiagnostics will now supply its product line to 36 regional offices of the American Red Cross, which distributes more than 40 percent of the nation’s blood supply. The agreement includes Quotient’…
August 15, 2010
NEWTOWN, Penn. (August 15, 2010)—Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to hospitals and blood banks, today announced that it has launched four new products including: ALBAcheck® - BGS Competency Training Kit, ALBAhance® PEG, ALBAhance® LISS Additive, and ALBAcheck® - BGS Simulated Whole Blood Controls.
Quotient has introduced the new ALBAcheck Competency T…
New Program Offers Significant Discounts to Schools Training MTs, MLTs, and SBBs
May 15, 2010
NEWTOWN, Penn. (May 15, 2010)
Quotient Biodiagnostics has launched its Reagent Access Program for Educators. Quotient designed the program to aid those institutions that are training the MTs, MLTs, and SBBs of tomorrow who are under constant budgetary constraints. The program offers some inventory for donation when available, but offers discounts of 50% to 75% every…
March 18, 2010
Haemonetics Corporation (NYSE; HAE), a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. This arrangement provides Haemonetics with exclusive access to Alba’s comprehensive catalogue of approved reagents for use in connection with the commercialization of its Arryx laser based blood typing…
AFFILIATED CENTERS ACCOUNT FOR 30 PERCENT OF NATION’S TRANSFUSION REQUIREMENTS
March 01, 2010
NEWTOWN, Penn. (March 1, 2010) - Quotient Biodiagnostics, Inc., today announced that it has entered into an agreement with Blood Centers of America (BCA) as a preferred vendor. BCA will actively promote Quotient’s product line to its 38 blood center member organizations, which account for 35 percent of the nation’s transfusion requirements. The deal will include …
